FDA awards Synchrogenix contract extension for eCTD Management Software
On June 15th, the United States Food and Drug Administration (US FDA) awarded Synchrogenix a contract extension for the electronic common technical document (eCTD) submission management software:
This contract extension provides a continuity in the drug review process and marks the 12th anniversary of the exclusive relationship. Since June 2005, the FDA has solely utilized GlobalSubmit REVIEW™ & GlobalSubmit VALIDATE™ solutions as their eCTD platform.
Synchrogenix remains committed to being a transparent and trustworthy partner. We will continue to create best in class eCTD review and validation software and provide updates as we continue our partnership with the US FDA.